首页
/视频回放
/Asciminib provides better efficacy and favorable safety and tolerability vainvestigators-selected tyrosine kinase inhibitors(lS TKl) in newly diagnosed chronimyeloid leukemia(CML):results from the east Asia subgroup analysis of the pivotalASC4First study
/
